Peter L. Wilson
Direktor/Vorstandsmitglied bei Conceptus SAS
Profil
Peter L.
Wilson is currently a Director at Conceptus SAS.
He was previously the President & CEO of Patient Education Systems, Inc. from 1995 to 1998, a Director at Keravision, Inc. from 1998 to 2001, and the Lead Independent Director at Arthrocare Corp.
from 2011 to 2013.
He also served as the President of Richardson-Vicks, Inc. and President of Vicks Healthcare at Procter & Gamble Co. from 1972 to 1992.
Mr. Wilson holds an MBA from The Trustees of Columbia University in The City of New York and an undergraduate degree from Princeton University.
Aktive Positionen von Peter L. Wilson
| Unternehmen | Position | Beginn |
|---|---|---|
Conceptus SAS
 Conceptus SAS Medical SpecialtiesHealth Technology Conceptus SAS is a subsidiary of Conceptus Inc. Conceptus is engaged in the design, development, promotion and distribution of innovative medical products for use in the field of women's health. The company Conceptus SAS is headquartered in Versailles France. | Direktor/Vorstandsmitglied | 30.05.2011 |
Ehemalige bekannte Positionen von Peter L. Wilson
| Unternehmen | Position | Ende |
|---|---|---|
Conceptus, Inc.
 Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Direktor/Vorstandsmitglied | 05.06.2013 |
| ARTHROCARE CORPORATION | Direktor/Vorstandsmitglied | 05.06.2013 |
Keravision, Inc.
 Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | Direktor/Vorstandsmitglied | 01.03.2001 |
Patient Education Systems, Inc.
 Patient Education Systems, Inc. Medical/Nursing ServicesHealth Services Patient Education Systems, Inc. provides healthcare information and related education services. The private company is based in Skillman, NJ. | Präsident | 01.01.1998 |
| Richardson-Vicks, Inc. | Präsident | 01.01.1992 |
Ausbildung von Peter L. Wilson
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| Princeton University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
| Private Unternehmen | 6 |
|---|---|
Arthrocare Corp.
 Arthrocare Corp. Medical SpecialtiesHealth Technology ArthroCare Corp. manufactures medical devices for cardiovascular, spinal and other medical treatments. The company was founded on April 29, 1993 and is headquartered in Memphis, TN. | Health Technology |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | Health Technology |
Conceptus, Inc.
Conceptus, Inc. Medical SpecialtiesHealth Technology Conceptus, Inc. develops and markets minimally invasive devices for reproductive medical applications. It sells its products through direct sales force and distribution networks to physicians and hospitals. The company was founded by Kathryn A. Tunstall in 1992 and is headquartered in Mountain View, CA. | Health Technology |
Conceptus SAS
Conceptus SAS Medical SpecialtiesHealth Technology Conceptus SAS is a subsidiary of Conceptus Inc. Conceptus is engaged in the design, development, promotion and distribution of innovative medical products for use in the field of women's health. The company Conceptus SAS is headquartered in Versailles France. | Health Technology |
Patient Education Systems, Inc.
Patient Education Systems, Inc. Medical/Nursing ServicesHealth Services Patient Education Systems, Inc. provides healthcare information and related education services. The private company is based in Skillman, NJ. | Health Services |
| Richardson-Vicks, Inc. |
